Artificial intelligence (AI) has seen significant investment in drug development, but success comes down to the quality of inputs and use of AI models, according to Niven R. Narain, CEO of BPGbio. GEN has compiled a list of 10 leading AI-based drug discovery and development companies, including Anima Biotech, Atomwise, BPGbio, Generate Biomedicines, Insilico Medicine, Model Medicines, Nimbus Therapeutics, Recursion Pharmaceuticals, Relay Therapeutics and Schrödinger.
Court hears that Cyberattack on Cabot, a debt acquisition company, resulted in theft of 394,000 data files – DataBreaches.Net
Well, it seems even in the world of credit servicing, companies are not safe from the menacing clutches of cyber crime. An interesting turn of
